Trial Profile
A phase Ib trial to investigate CAVATAK and a checkpoint inhibitor in colorectal cancer metastatic to the liver
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2018
Price :
$35
*
At a glance
- Drugs Gebasaxturev (Primary) ; Pembrolizumab
- Indications Colorectal cancer
- Focus Adverse reactions
- 29 Mar 2018 According to an Immutep Limited media release, this trial is planned to start in 2018.
- 23 Nov 2017 New trial record